Modern mammography screening and breast cancer mortality: population study
暂无分享,去创建一个
L. Vatten | P. Romundstad | H. Weedon-Fekjær | Lars J Vatten | Pål R Romundstad | Harald Weedon-Fekjær
[1] Eugenio Paci,et al. Summary of the Evidence of Breast Cancer Service Screening Outcomes in Europe and First Estimate of the Benefit and Harm Balance Sheet , 2012, Journal of medical screening.
[2] P. Glynn,et al. A stochastic simulation model of U.S. breast cancer mortality trends from 1975 to 2000. , 2006, Journal of the National Cancer Institute. Monographs.
[3] E. Lynge,et al. Estimating The Benefits of Mammography Screening: The Impact of Study Design , 2007, Epidemiology.
[4] E. Paci,et al. Assessment of the early impact of the population-based breast cancer screening programme in Florence (Italy) using mortality and surrogate measures. , 2002, European journal of cancer.
[5] Jack Cuzick,et al. Effects of adjuvant tamoxifen and of cytotoxic therapy on mortality in early breast cancer. An overview of 61 randomized trials among 28,896 women , 1988 .
[6] Elsebeth Lynge,et al. Breast cancer mortality in Copenhagen after introduction of mammography screening: cohort study , 2005, BMJ : British Medical Journal.
[7] D. Berry,et al. Effect of screening and adjuvant therapy on mortality from breast cancer. , 2006, The New England journal of medicine.
[8] A. Ellis. Breast , 2002, BMJ : British Medical Journal.
[9] M. Kumle,et al. Breast cancer mortality in Norway after the introduction of mammography screening , 2013, International journal of cancer.
[10] A. Miller. Screening for breast cancer with mammography , 2001, The Lancet.
[11] B. Møller,et al. Breast cancer mortality in participants of the Norwegian Breast Cancer Screening Program , 2013, Cancer.
[12] Eugenio Paci,et al. Breast Cancer Mortality in Mammographic Screening in Europe: A Review of Incidence-Based Mortality Studies , 2012, Journal of medical screening.
[13] J. Skelly,et al. Comparing screening mammography for early breast cancer detection in Vermont and Norway. , 2008, Journal of the National Cancer Institute.
[14] L. Vatten,et al. Understanding recent trends in incidence of invasive breast cancer in Norway: age-period-cohort analysis based on registry data on mammography screening and hormone treatment use , 2012, BMJ : British Medical Journal.
[15] Peter C Gøtzsche,et al. Is screening for breast cancer with mammography justifiable? , 2000, The Lancet.
[16] EUROSCREENWorking Group,et al. Summary of the evidence of breast cancer service screening outcomes in Europe and first estimate of the benefit and harm balance sheet , 2012 .
[17] P. Gøtzsche,et al. Screening for breast cancer with mammography. , 2013, The Cochrane database of systematic reviews.
[18] M Broeders,et al. The Impact of Mammographic Screening on Breast Cancer Mortality in Europe: A Review of Trend Studies , 2012, Journal of medical screening.
[19] Marvin Zelen,et al. Effect of screening mammography on breast-cancer mortality in Norway. , 2010, The New England journal of medicine.
[20] Eero Pukkala,et al. Health effects of obstructive sleep apnoea and the effectiveness of continuous positive airways pressure: a systematic review of the research evidence , 1997, BMJ.
[21] P. Skaane,et al. Trends in incidence of ductal carcinoma in situ: the effect of a population-based screening programme. , 2010, Breast.
[22] Annette Dobson,et al. Mammography screening and breast cancer mortality in Australia: an aggregate cohort study , 2012, Journal of medical screening.
[23] C. Pipper,et al. [''R"--project for statistical computing]. , 2008, Ugeskrift for laeger.
[24] Ingvar Andersson,et al. Long-term effects of mammography screening: updated overview of the Swedish randomised trials , 2002, The Lancet.
[25] Philippe Autier,et al. Breast cancer mortality in neighbouring European countries with different levels of screening but similar access to treatment: trend analysis of WHO mortality database , 2011, BMJ : British Medical Journal.
[26] M. Kumle,et al. Mammography activity in Norway 1983 to 2008 , 2011, Acta oncologica.
[27] P. Gøtzsche,et al. Breast cancer mortality in organised mammography screening in Denmark: comparative study , 2010, BMJ : British Medical Journal.
[28] Angela Mariotto,et al. Cancer Intervention and Surveillance Modeling Network (CISNET) , 2001, Journal of Investigative Medicine.
[29] D. Altman,et al. The benefits and harms of breast cancer screening: an independent review , 2012, British Journal of Cancer.
[30] P. Skaane,et al. Overdiagnosis among women attending a population-based mammography screening program , 2013, International journal of cancer.
[31] Bjørn Møller,et al. Data quality at the Cancer Registry of Norway: an overview of comparability, completeness, validity and timeliness. , 2009, European journal of cancer.
[32] Jacques Ferlay,et al. NORDCAN – a Nordic tool for cancer information, planning, quality control and research , 2010, Acta oncologica.
[33] J. Castilla,et al. Changes in breast cancer mortality in Navarre (Spain) after introduction of a screening programme , 2007, Journal of medical screening.
[34] H. Welch. Screening mammography--a long run for a short slide? , 2010, The New England journal of medicine.
[35] Mike Clarke,et al. Tamoxifen for early breast cancer: an overview of the randomised trials , 1998, The Lancet.